Division of Pharmacology Seminars
Title: Overview of the Conduct of Early Clinical Trials in Healthy Subjects at OSU - Regulations, Design of Studies, and Facilities
by Glen Apseloff, M.D., F.C.P. Director of Clinical Trials, Research Professor, Dept. of Pharmacology, College of Medicine.
Date & Time: September 24, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: Biology + Delivery + Pharmacodynamics + Computation = Greater Success in Cancer Drug Development
by Jessie L-S Au, PharmD, PhD, Distinguished University Professor, Division of Pharmaceutics.
Date & Time: October 01, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: H3 Receptor Antagonists: Preclinical Promise for Treating Cognitive Disorders
by Tim Esbenshade, Ph.D., Senior Group Leader & Associate Fellow, Neuroscience Research, Abbott Laboratories, Abbott Park, IL.
Date & Time: October 08, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: Expression Genetics: New Approach to Optimizing Drug Therapy
by Wolfgang Sadee, Dr.rer.nat, Felts Mercer Professor of Medicine & Pharmacology; Director, Program in Pharmacogenomics, OSU College of Medicine.
Date & Time: October 22, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: HTS-ing Towards Functionally Selective Allosteric Modulators of the Dopamine Receptor
by R. Benjamin Free, Ph.D., Molecular Neuropharmacology Section, NIH/National Institute of Neurological Diseases & Stroke, Bethesda, MD.
Date & Time: October 29, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: A Behavioral Genetics Approach to Understanding Nicotine Reinforcement: Novel Opportunities for Therapeutics Development
by Paul J. Kenny, Ph.D., Associate Professor, Laboratory for Behavioral and Molecular Neuroscience, Department of Molecular Therapeutics, The Scripps Research Institute, Juniper, FL.
Date & Time: December 03, 2009 11:30 AM
Seminar Location: 202 Parks Hall
by Glen Apseloff, M.D., F.C.P. Director of Clinical Trials, Research Professor, Dept. of Pharmacology, College of Medicine.
Date & Time: September 24, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: Biology + Delivery + Pharmacodynamics + Computation = Greater Success in Cancer Drug Development
by Jessie L-S Au, PharmD, PhD, Distinguished University Professor, Division of Pharmaceutics.
Date & Time: October 01, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: H3 Receptor Antagonists: Preclinical Promise for Treating Cognitive Disorders
by Tim Esbenshade, Ph.D., Senior Group Leader & Associate Fellow, Neuroscience Research, Abbott Laboratories, Abbott Park, IL.
Date & Time: October 08, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: Expression Genetics: New Approach to Optimizing Drug Therapy
by Wolfgang Sadee, Dr.rer.nat, Felts Mercer Professor of Medicine & Pharmacology; Director, Program in Pharmacogenomics, OSU College of Medicine.
Date & Time: October 22, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: HTS-ing Towards Functionally Selective Allosteric Modulators of the Dopamine Receptor
by R. Benjamin Free, Ph.D., Molecular Neuropharmacology Section, NIH/National Institute of Neurological Diseases & Stroke, Bethesda, MD.
Date & Time: October 29, 2009 11:30 AM
Seminar Location: 202 Parks Hall
Title: A Behavioral Genetics Approach to Understanding Nicotine Reinforcement: Novel Opportunities for Therapeutics Development
by Paul J. Kenny, Ph.D., Associate Professor, Laboratory for Behavioral and Molecular Neuroscience, Department of Molecular Therapeutics, The Scripps Research Institute, Juniper, FL.
Date & Time: December 03, 2009 11:30 AM
Seminar Location: 202 Parks Hall
[ back to top ]